I agree that this site is using cookies. You can find further informations here.
X
Christensen, Claus Uhrenholt
14  results:
Search for persons X
?
1

Niemann-Pick type C2 protein supplementation in experimenta..:

Christensen, Claus Uhrenholt ; Glavind, Emilie ; Thomsen, Karen Louise...
PLOS ONE.  13 (2018)  3 - p. e0192728 , 2018
Link: https://doi.org/10.1371/..
 
?
2

Activation Markers CD63 and CD203c Are Upregulated in Chron..:

Christensen, Claus Uhrenholt ; Vestergaard, Christian ; Hoffmann, Hans Jürgen
Annals of Dermatology.  25 (2013)  4 - p. 522 , 2013
Link: https://doi.org/10.5021/..
 
?
3

Niemann-Pick type C2 protein supplementation in experimenta..:

Christensen, Claus Uhrenholt ; Glavind, Emilie ; Thomsen, Karen Louise...
https://pure.au.dk/portal/da/publications/niemannpick-type-c2-protein-supplementation-in-experimental-nonalcoholic-fatty-liver-disease(4533196d-bef3-4577-b8c2-49d7ba5bc35c).html.  , 2018
Link: https://pure.au.dk/porta..
 
?
4

Niemann-Pick type C2 protein supplementation in experimenta..:

Claus Uhrenholt Christensen ; Emilie Glavind ; Karen Louise Thomsen...
http://europepmc.org/articles/PMC5844539?pdf=render.  , 2018
Link: https://doi.org/10.1371/..
 
?
5

Fundamentals of Hydrofaction™: Renewable crude oil from woo..:

Jensen, Claus Uhrenholt ; Rodriguez Guerrero, Julie Katerine ; Karatzos, Sergios..
Biomass Conversion and Biorefinery.  7 (2017)  4 - p. 495-509 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Co-processing potential of HTL bio-crude at petroleum refin..:

Hoffmann, Jessica ; Jensen, Claus Uhrenholt ; Rosendahl, Lasse A.
Fuel.  165 (2016)  - p. 526-535 , 2016
Link: https://doi.org/10.1016/..
 
?
7

Co-processing potential of HTL bio-crude at petroleum refin..:

Jensen, Claus Uhrenholt ; Hoffmann, Jessica ; Rosendahl, Lasse A.
Fuel.  165 (2016)  - p. 536-543 , 2016
Link: https://doi.org/10.1016/..
 
?
8

Effects of Anti-TNFαTreatment on Mucosal Expression of IL-1..:

Dige, Anders ; Magnusson, Maria K. ; Uhrenholt, Claus...
Mediators of Inflammation.  2018 (2018)  - p. 1-7 , 2018
Link: https://doi.org/10.1155/..
 
?
9

Exploring TNFi drug-levels and anti-drug antibodies during ..:

Uhrenholt, Line ; Sørensen, Mads E. R. ; Lauridsen, Karen B....
Rheumatology International.  , 2024
Link: https://doi.org/10.1007/..
 
?
10

Predicting successful biologics tapering in patients with i..:

Uhrenholt, Line ; Duch, Kirsten ; Christensen, Robin...
British Journal of Clinical Pharmacology.  89 (2023)  10 - p. 3152-3164 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Pupillary dilation velocity is reduced in intensive care un..:

Uhrenholt, Stine ; Linér, Signe Maria ; Stokholm, Jannik..
Acta Anaesthesiologica Scandinavica.  68 (2023)  1 - p. 56-62 , 2023
Link: https://doi.org/10.1111/..
 
?
12

Risk of flare after tapering or withdrawal of biologic/targ..:

Uhrenholt, Line ; Christensen, Robin ; Dinesen, Wilfred K H...
Rheumatology.  61 (2021)  8 - p. 3107-3122 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Patient-reported outcome measures in systemic lupus erythem..:

Uhrenholt, Line ; Høstgaard, Simone ; Pedersen, Julie F...
Lupus.  30 (2021)  13 - p. 2124-2134 , 2021
Link: https://doi.org/10.1177/..
 
?
14

Dosage reduction and discontinuation of biological disease-..:

Uhrenholt, Line ; Schlemmer, Annette ; Hauge, Ellen-Margrethe...
BMJ Open.  9 (2019)  7 - p. e028517 , 2019
Link: https://doi.org/10.1136/..
 
1-14